Abstract
The use of genetic engineering to generate point mutations in induced pluripotent stem cells (iPSCs) is essential for studying a specific genetic effect in an isogenic background. We demonstrate that a combination of p53 inhibition and pro-survival small molecules achieves a homologous recombination rate higher than 90% using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) in human iPSCs. Our protocol reduces the effort and time required to create isogenic lines.
Original language | English (US) |
---|---|
Article number | 9933 |
Journal | Scientific reports |
Volume | 14 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2024 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024.
Keywords
- CRISPR
- Gene editing
- High efficiency
- Single nucleotide polymorphism
- iPSC
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't